Sangamo Therapeutics
SGMO
SGMO
222 hedge funds and large institutions have $1.22B invested in Sangamo Therapeutics in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 69 increasing their positions, 71 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
222
Holders Change
+12
Holders Change %
+5.71%
% of All Funds
3.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
39
Increased
69
Reduced
71
Closed
26
Calls
$40.6M
Puts
$22.4M
Net Calls
+$18.1M
Net Calls Change
+$15M
Top Buyers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
$157M |
| 2 |
JPMorgan Chase & Co
New York
|
$27.8M |
| 3 |
Goldman Sachs
New York
|
$38.7M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
$9.19M |
| 5 |
Morgan Stanley
New York
|
$12.7M |
